Leiner
This article was originally published in The Tan Sheet
Executive Summary
Gross inventory down $45.4 mil. to $133.9 mil. at second quarter's end compared to prior-year period, reflecting "complexity reduction and supply chain reengineering," company says Nov. 14. Restructuring professional fees and expenses comprised $3.1 mil. of $5.1 mil. in non-recurring expenses for Q2 ended Sept. 30. Sales fell 8% to $151.6 mil. for the quarter, but gross profit as a percentage of sales improved to 21.8% from 21.3% a year ago due to better plant efficiencies, discontinuation of less profitable SKUs. Net loss jumped to $11.9 mil. from $2.6 mil. in prior-year quarter. On Nov. 2, Leiner announced plans to file for Chapter 11 protection in early 2002 (1"The Tan Sheet" Nov. 12, p. 11)...
You may also be interested in...
Leiner Chapter 11 Plan To Include New Capital, Credit, Debt Restructuring
Leiner Health Products will use a tentative $20 mil. equity investment to support ongoing operations as it prepares to seek Chapter 11 protection in early 2002, the company stated
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.